.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Merck
Fish and Richardson
Healthtrust
Fuji
Novartis
Chinese Patent Office
Covington
Dow
Citi

Generated: July 23, 2017

DrugPatentWatch Database Preview

Teva Branded Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for TEVA BRANDED PHARM, and what generic alternatives to TEVA BRANDED PHARM drugs are available?

TEVA BRANDED PHARM has twenty-five approved drugs.

There are forty-five US patents protecting TEVA BRANDED PHARM drugs.

There are five hundred and sixty-one patent family members on TEVA BRANDED PHARM drugs in thirty-seven countries.

Summary for Applicant: Teva Branded Pharm

Patents:45
Tradenames:24
Ingredients:14
NDAs:25
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm
PROAIR RESPICLICK
albuterol sulfate
POWDER, METERED;INHALATION205636-001Mar 31, 2015RXYesYes8,651,103► SubscribeY ► Subscribe
Teva Branded Pharm
ZECUITY
sumatriptan succinate
SYSTEM;IONTOPHORESIS202278-001Jan 17, 2013DISCNYesNo8,366,600► Subscribe ► Subscribe
Teva Branded Pharm
VANTRELA ER
hydrocodone bitartrate
TABLET, EXTENDED RELEASE;ORAL207975-005Jan 17, 2017RXYesNo9,572,803► SubscribeY ► Subscribe
Teva Branded Pharm
ZECUITY
sumatriptan succinate
SYSTEM;IONTOPHORESIS202278-001Jan 17, 2013DISCNYesNo8,983,594► SubscribeY ► Subscribe
Teva Branded Pharm
AUSTEDO
deutetrabenazine
TABLET;ORAL208082-003Apr 3, 2017RXYesYes9,233,959► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Teva Branded Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded Pharm
SEASONALE
ethinyl estradiol; levonorgestrel
TABLET;ORAL021544-001Sep 5, 2003RE39861► Subscribe
Teva Branded Pharm
QVAR 80
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-001Sep 15, 20005,776,432► Subscribe
Teva Branded Pharm
PROAIR HFA
albuterol sulfate
AEROSOL, METERED;INHALATION021457-001Oct 29, 20048,834,849► Subscribe
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813-001Mar 23, 20125,605,674► Subscribe
Teva Branded Pharm
QVAR 40
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-002Sep 15, 20005,683,677► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for TEVA BRANDED PHARM drugs

Drugname Dosage Strength Tradename Submissiondate
levonorgestrel; ethinyl estradiol;ethinyl estradiol
Tablets0.15 mg/0.02 mg, 0.15 mg/0.025 mg, 0.15 mg/0.03 mg and 0.01 mg
QUARTETTE
7/10/2013
levonorgestrel;ethinyl estradiol;ethinyl estradiol
Tablets0.1 mg/0.02 mg and 0.01 mg
LOSEASONIQUE
11/16/2009
conjugated estrogen (synthetic a)
Tablets0.3 mg, 0.45 mg and 0.9 mg
CENESTIN
3/19/2009
conjugated estrogen (synthetic a)
Tablets0.625 mg
CENESTIN
3/2/2009
conjugated estrogen (synthetic a)
Tablets1.25 mg
CENESTIN
11/3/2008
levonorgestrel; ethinyl estradiol; ethinyl estradiol
Tablets0.15 mg/0.03 mg/0.01 mg
SEASONIQUE
1/22/2008
levonorgestrel and ethinyl estradiol
Tablets0.15 mg/0.03 mg
SEASONALE
3/29/2004

Premature patent expirations for TEVA BRANDED PHARM

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
► Subscribe ► Subscribe

Non-Orange Book Patents for Teva Branded Pharm

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,743,413 Suspension aerosol formulations► Subscribe
7,749,989Estrogenic compounds, methods of using and methods of administering the same► Subscribe
9,108,010Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
7,989,436Estrogenic compounds and pharmaceutical formulations comprising the same► Subscribe
7,772,219Methods of hormonal treatment utilizing extended cycle contraceptive regimens► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Teva Branded Pharm Drugs

Country Document Number Estimated Expiration
South Korea100663113► Subscribe
Eurasian Patent Organization201300237► Subscribe
Canada2727927► Subscribe
Canada2582530► Subscribe
New Zealand603398► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Teva Branded Pharm Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0001France► SubscribePRODUCT NAME: ETHINYLESTRADIOL BETADEX CLATHRATE; NAT. REGISTRATION NO/DATE: NL 32343 20060710; FIRST REGISTRATION: NL - RVG 31781 20050804
2015000093Germany► SubscribePRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129
2009 00017Denmark► SubscribePRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629
00221Netherlands► SubscribePRODUCT NAME: DROSPIRENON EN ETHINYLESTRADIOL; REGISTRATION NO/DATE: RVG 23827 20000307
0160011 00192Estonia► SubscribePRODUCT NAME: LEVONORGESTREEL JA ETUENUEUELOESTRADIOOL;REG NO/DATE: EE 894715 11.11.2015
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Dow
Cipla
US Department of Justice
Novartis
Chinese Patent Office
Merck
US Army
Johnson and Johnson
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot